X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs BIOCON LTD - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD BIOCON LTD STRIDES SHASUN LTD/
BIOCON LTD
 
P/E (TTM) x 44.0 92.4 47.6% View Chart
P/BV x 1.1 7.8 14.0% View Chart
Dividend Yield % 0.9 0.1 612.8%  

Financials

 STRIDES SHASUN LTD   BIOCON LTD
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
BIOCON LTD
Mar-18
STRIDES SHASUN LTD/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1,2751,188 107.3%   
Low Rs918305 301.0%   
Sales per share (Unadj.) Rs389.668.7 566.8%  
Earnings per share (Unadj.) Rs28.07.6 370.4%  
Cash flow per share (Unadj.) Rs48.914.0 350.0%  
Dividends per share (Unadj.) Rs4.501.00 450.0%  
Dividend yield (eoy) %0.40.1 306.4%  
Book value per share (Unadj.) Rs303.186.3 351.0%  
Shares outstanding (eoy) m89.42600.00 14.9%   
Bonus/Rights/Conversions ESOPIS-  
Price / Sales ratio x2.810.9 25.9%   
Avg P/E ratio x39.298.9 39.7%  
P/CF ratio (eoy) x22.453.4 42.0%  
Price / Book Value ratio x3.68.6 41.8%  
Dividend payout %16.113.2 121.5%   
Avg Mkt Cap Rs m98,036447,900 21.9%   
No. of employees `0005.86.1 94.3%   
Total wages/salary Rs m5,8819,311 63.2%   
Avg. sales/employee Rs Th6,005.96,705.8 89.6%   
Avg. wages/employee Rs Th1,014.01,514.2 67.0%   
Avg. net profit/employee Rs Th431.2736.9 58.5%   
INCOME DATA
Net Sales Rs m34,83441,234 84.5%  
Other income Rs m1,6862,062 81.8%   
Total revenues Rs m36,52043,296 84.3%   
Gross profit Rs m6,4288,291 77.5%  
Depreciation Rs m1,8723,851 48.6%   
Interest Rs m2,269615 369.0%   
Profit before tax Rs m3,9735,887 67.5%   
Minority Interest Rs m0213 0.0%   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m4701,569 30.0%   
Profit after tax Rs m2,5014,531 55.2%  
Gross profit margin %18.520.1 91.8%  
Effective tax rate %11.826.7 44.4%   
Net profit margin %7.211.0 65.3%  
BALANCE SHEET DATA
Current assets Rs m38,16541,486 92.0%   
Current liabilities Rs m30,40221,413 142.0%   
Net working cap to sales %22.348.7 45.8%  
Current ratio x1.31.9 64.8%  
Inventory Days Days7764 120.9%  
Debtors Days Days10494 110.9%  
Net fixed assets Rs m37,63950,661 74.3%   
Share capital Rs m8943,000 29.8%   
"Free" reserves Rs m26,21048,808 53.7%   
Net worth Rs m27,10551,808 52.3%   
Long term debt Rs m16,37717,898 91.5%   
Total assets Rs m81,16899,897 81.3%  
Interest coverage x2.810.6 26.0%   
Debt to equity ratio x0.60.3 174.9%  
Sales to assets ratio x0.40.4 104.0%   
Return on assets %5.95.2 114.1%  
Return on equity %9.28.7 105.5%  
Return on capital %12.19.6 125.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m13,46512,058 111.7%   
Fx outflow Rs m4,0767,348 55.5%   
Net fx Rs m9,3894,710 199.4%   
CASH FLOW
From Operations Rs m2,8816,621 43.5%  
From Investments Rs m-7,051-6,840 103.1%  
From Financial Activity Rs m3,382-2,397 -141.1%  
Net Cashflow Rs m-788-2,612 30.2%  

Share Holding

Indian Promoters % 27.7 40.4 68.6%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 37.8 8.4 450.0%  
FIIs % 8.6 10.7 80.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 19.9 130.2%  
Shareholders   56,241 109,995 51.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  GLENMARK PHARMA  GSK PHARMA  PANACEA BIOTECH  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

STRIDES SHASUN LTD Announces Quarterly Results (1QFY19); Net Profit Down 57.5% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, STRIDES SHASUN LTD has posted a net profit of Rs 38 m (down 57.5% YoY). Sales on the other hand came in at Rs 7 bn (down 21.2% YoY). Read on for a complete analysis of STRIDES SHASUN LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Sep 21, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - VENUS REMEDIES COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS